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Abstract A decade of genetic counseling of frontotemporal
dementia (FTD) affected families has generated two impor-
tant observations. First, the uptake rate for presymptomatic
testing for FTD is low in our department of Clinical Genetics
at the Erasmus Medical Center in the Netherlands. Second,
FTD at-risk counselees reported substantial familial opposi-
tion to genetic testing, which is distinct from the attitude in
Huntington Disease affected families. We hypothesize that
the low acceptance for FTD genetic counseling is conse-
quential to the familial opposition and explain this within the
theoretical framework of separation-individuation. Further-
more, we hypothesize that separation-individuation problems
do not similarly influence the acceptance of HD genetic
counseling, due to the educative role of the well-organised
patient organization for HD in the Netherlands. We offer
counseling recommendations that serve to facilitate the
individuation of the counselee with respect to the FTD
genetic test.
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Frontotemporal Dementia
Frontotemporal dementia (FTD) is a severe neurodegener-
ative disorder with onset at middle-adult age. Patients
present with decline in interpersonal conduct, emotional
blunting and loss of insight, all preceding memory decline
(Snowden et al. 2002). As FTD advances, patients develop
progressive disturbance of executive functions, loss of
initiative, mental flexibility and organization. Language
becomes impaired, eventually resulting in aphasia. FTD is
the second most common presenile dementia, with a
prevalence of 10–15 per 100.000 individuals of 45–65 years
(Mercy et al. 2008; Rosso et al. 2003; van Swieten and
Heutink 2008). There are identical risks for male and
female offspring of an affected parent in the familial forms,
which are estimated at 30–50% of total FTD (Rosso et al.
2003; Seelaar et al. 2008).
Mutations are found in 30–40% of cases with a positive
family history (Rosso et al. 2003; Van der Zee et al. 2008;
Van Swieten et al. 2004). There are at least five genes
associated with FTD and its subtypes, and even more when
one considers the overlap with Alzheimer disease and
motor neuron disease (Van der Zee et al. 2008). The
microtubule associated protein tau gene (MAPT) was the
first FTD gene identified in 1998 (Sleegers et al. 2008),
followed by the progranulin gene (GRN) in 2006. The
MAPT and GRN mutations are variably found in some 10–
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20% of familial FTD series (Rademakers et al. 2007;
Rademakers et al. 2008). The mean age of onset of FTD
with a MAPT mutation is 52.4±5.9 years (Van Swieten et
al. 2004) and with a GRN mutation it is 61.8±9.9 years
(Rademakers et al. 2008; Seelaar et al. 2008). For both
diseases, the penetrance is high, that is, 90–95% of
mutation carriers will become affected by 70 years. The
clinical spectrum seen with identical mutations may vary
from Alzheimer disease, Lewy Body disease, corticobasal
syndrome, frontotemporal dementia, frontotemporal lobar
dementia, FTD-ALS to primary progressive aphasia, etc.
When the disease-causing gene is identified in a family,
presymptomatic genetic testing becomes available. With the
discovery of FTD causing genes (see for a review: Van
Swieten 2007) gradually more families will be able to opt
for genetic testing of patients, at-risk relatives and prenatal
testing. However, the number of families tested for the less
frequently observed mutations is still limited, which implies
insufficient knowledge on the clinical variability of these
mutations.
Genetic Counseling in the Netherlands
In presymptomatic genetic testing, healthy relatives, usually
siblings or children of identified FTD probands, are enabled
to obtain testing for the mutation causing FTD in their
family. Family-specific and mutation-specific data on
variability in age at onset and progression of the behavioral
problems of FTD will be given, emphasizing the remaining
uncertainties for newly identified gene carriers. The genetic
counseling approach for FTD is similar to that for
Huntington’s disease (HD) (Brouwer-DudokdeWit et al.
2002) and involves three steps: intake, blood withdrawal,
and test result disclosure in two or three sessions depending
on the extent of information and decision process prior to
the first visit. The counselee is seen by a clinical geneticist
and a psychosocial counselor at all visits.
At intake, the clinical geneticist informs the counselee
about FTD, the specific FTD related problems in the family,
and the possible implications of testing. The geneticist aims
to facilitate the counselee’s decision-making about the
choice for the test and its implications for his or her future.
Special attention is given to social support in- or outside the
family and to possible problems of obtaining employment
and life- or other insurance when an FTD carrier status is
found. Referral to specific information services is offered.
At test disclosure the geneticist facilitates counselee
expression of initial emotional reactions to the news and
offers follow-up to support the counselee in coping with his
or her new status, either as disease free or as a mutation
carrier. The goal is adequate integration of the counselee’s
new status in daily living.
Psychosocial counselors, at intake, explore in-depth the
motivation to seek testing, in order to raise awareness of the
counselee’s expectations with respect to testing. Counselees
are encouraged to think about what a favorable or an
unfavorable test result would mean to them personally, in
order to make a head start in psychological processing of
any test outcome. How does the counselee expect to feel
upon hearing that she or he is or is not a carrier of the gene?
What would change? How will either outcome affect the
bonds within the family? How will the counselee maintain
quality of life awaiting a future of FTD? Preparing for the
outcome means anticipating a rather dramatic change: from
uncertainty and hope towards certainty, with either a future
with increasing distress, or liberated from the disease but
possibly burdened for some period by guilt feelings towards
affected relatives. In addition, the geneticist provides
technical information on the genetics of FTD, the pheno-
type and penetrance, whereas the psychosocial counselor
explores in-depth the psychological make-up and motiva-
tion of the counselee and the family dynamics with regard
to the hereditary disorder, and discusses how this counselee
may best adapt to either test outcome. Furthermore, the
psychosocial counselor provides follow-up, and if neces-
sary, referral to psychotherapy.
Clinical Experience with Genetic Counseling for FTD
in Rotterdam
Mutation analyses for presymptomatic testing for FTD in
the Netherlands were only performed in our Rotterdam
diagnostic laboratory until 2007. The diagnostic laboratory
of the Free University in Amsterdam has performed a few
analyses since 2007. Nearly all counselees were seen at the
department of Clinical Genetics of the Erasmus Medical
Centre in Rotterdam. We made several important observa-
tions about clinical genetic testing for FTD. First, the
uptake rate seemed to be quite low. After the identification
of pathogenic MAPT mutations in 1997, 80 members of
three large families who were at 50% risk and > 18 years of
age, were informed of the discovery of the pathogenic
genes and were offered genetic counseling (Heutink et al.
1997). We estimated that this information would also reach
another 100 adults at 50% risk in these families, and
possibly more relatives at lower risk. Only thirteen
individuals from this potential group of 180 people that
were at 50% risk of being carriers requested genetic
counseling between 1999 and 2002. Since we cannot be
certain that the additional 100 adults were actually reached,
the acceptance of counseling ranges somewhere between 7
and 17%. The 13 counselees were on average 34 years of
age (Range: 19–54), and of these counselees, 6 pursued the
test. Five of these testees stated that resolving unbearable
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uncertainty with regard to carrying the mutation was an
important motive for testing.
Since then, despite the discovery of other pathogenic
FTD genes (Bronner et al. 2007; Seelaar et al. 2008), a
mere 13 additional individuals have been counseled for
FTD in our center between 2003 and 2008. Furthermore,
during this decade (1999–2008) we received only one
request for prenatal diagnosis (PND) in 1999, and no
requests for pre-implantation genetic diagnosis (PGD) for
FTD. The low uptake for FTD presymptomatic testing is in
great contrast with the 24% uptake rate for Huntington’s
disease (HD) in the Netherlands in 2000 (Maat-Kievit et al.
2000), but it is comparable to low uptake rates for HD in
other countries (Tibben 2007).
In our clinical work we have made some characteristic
observations about our FTD population that warrant special
note. Two of us (SR and AT) have counseled all at-risk
individuals who presented themselves in our department for
FTD counseling since 1999. All of these counselees reported
experiencing clear opposition to genetic testing from their
family members. Healthy parents of counselees disapproved
of testing and siblings attempted to dissuade them from
testing; they were resentful about the counselees’ wish to
discuss the hereditary nature of FTD within the nuclear
family. Some counselees indicated that they consciously
used the genetic test to liberate themselves from their
oppressive and restrictive family. For them, genetic testing
for FTD would either enable an independent, disease free
life, or anticipation of a future disease without the additional
burden of problematic family dynamics.
Possible Explanation for Few FTD Genetic Test
Requests: the Importance of Separation-Individuation
Family members play an important role in the decision
whether or not to pursue genetic testing (Bowles Biesecker et
al. 2000; McDaniel 2005). The low uptake for FTD genetic
testing may result from a high prevalence of enmeshed
family structures and its effects on separation-individuation
processes. The concept of separation-individuation was
originally formulated by Margaret Mahler and refers to an
intra-psychic process that infants go through in early
childhood in ending their symbiotic relationship with their
mother (Mahler 1963). Separation refers to the realization of
self versus not self, and individuation pertains to the process
of determining who and what the self is.
A second separation-individuation phase begins in
adolescence and is generally seen as a transition of major
importance in the family life cycle (Daniels 1990). Therein,
young adults gain their independence from their family of
origin while continuing to have a function in the family.
During this phase adolescents develop relationships with
peers, or a partner that become equally important as the
relationship with the parents (Grootevant and Cooper 1986).
Generally, the second phase of separation-individuation is
thought to start in adolescence, but it remains a lifetime task
(White et al. 1983).
From this family systems perspective separation-
individuation is seen as the interchange between individual-
ity and connectedness between the individual and the nuclear
family members. We consider the separation-individuation
process to be of major importance in the clinical genetics
setting. A counselee who is sufficiently individuated is able
to distinguish his or her feelings and wishes from the feelings
and wishes of the nuclear family. A desire to pursue genetic
testing then, is a wish that has its origin in the counselee and
the counselee is free to assume the responsibility for
processing the information and emotions surrounding the
test and to cope with the result. Self-determination is
combined with respectful acceptance of and disengagement
from the feelings and reactions of the nuclear family. The
counselee is able to tolerate that other family members deal
with the genetic risk in her or his own way.
When counselees have not adequately accomplished the
separation-individuation task, relations with the nuclear
family are either enmeshed or disrupted. In enmeshed
families the counselees’ motives for testing tend to be fused
with the normative values of their family. These counselees
may pursue testing because the nuclear family pushes them
in that direction or, on the contrary, refrain from testing
under familial pressure. In enmeshed families taboo and
secrecy frequently surround the disease. Genetic testing in
such families may be instrumental allowing counselees to
“escape” from family enmeshment. An unfavorable test
result might excuse them from caregiver obligations,
whereas a favorable outcome might empower them to build
a new life.
Based on our decade of experience, FTD families seem
to be particularly enmeshed. Several processes threatening
adequate separation-individuation in FTD families may
promote such enmeshment. First, in dealing with illness
families tend to become more cohesive to carry the burden
together (Rolland 1987). Such cohesion implies that in the
face of a common threat families tend to stick together to
support each other. To a certain degree family members will
benefit from this cohesion. However, as Olson’s (2000)
Circumplex Model of family functioning describes, when
the cohesion becomes too strong individual family mem-
bers have less space to cope in their unique way, and the
family becomes enmeshed. Enmeshed families become
normative and exert pressure on members who deviate
from this norm. Such enmeshment interferes with adequate
separation-individuation.
Second, Goldman and colleagues (2004) noted that
families affected by FTD seem to be psychologically
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damaged. Psychological damage may occur as a conse-
quence of having an FTD- affected parent; FTD patients
have inhibition problems. Their behavior is therefore a
product of their impulses, which may cause them to be
aggressive, promiscuous, unpredictable, etc. They lack
disease insight, which results in their denial that anything is
wrong. In addition, they become emotionally blunted and are
unable to care about others. Furthermore, their executive
functions are damaged, and therefore their ability to organize
and plan activities is impaired. Clearly, FTD patients are
unable to provide a stable and safe environment for their
children in practical and emotional terms (Fanos 1997).
One of the most damaging aspects of FTD for family
members is that these symptoms occur early in the disease
process. Depending on the age of the children who are
faced with a parent with FTD, they will be more or less
prone to psychological damage. Children in the preverbal
phase are especially prone to develop an insecure attach-
ment style as has been demonstrated in HD families (Van
der Meer et al. 2006). For these children, their parent’s
behavior will be particularly threatening. Insecure attach-
ment combined with traumatic experience will lead to
dysfunction with respect to several developmental process-
es, including separation-individuation (van Gael 2002).
If the parent develops FTD when the child is in
adolescence, the separation-individuation process is at-risk.
For adequate separation-individuation it is important that
adolescents are able to rely on a stable relationship with their
parents. Adolescents need the space to find out who they are
and who they are not, but they also need to feel sufficient
connectedness with their parents so that in this “letting go”
process they do not lose their foundation (Barber 1997; Blos
1967). Adolescents with an FTD-affected parent may feel
isolated because they are too embarrassed about their
parent’s behavior to bring friends home, and they may be
unable to share their grief with their peers because generally
adolescents do not have to deal with losing a parent. Given
this complex situation at home, it may be more difficult to
allow peers to become equally important as the nuclear
family members (Carter and McGoldrick 2005).
Finally, it may be hypothesized that preoccupation with the
future disease threatens adequate separation-individuation. In
families affected by genetic disease young people may be
preoccupied with the apprehension they will develop the
disease in the future. This might be considered as “anticipa-
tory loss” and a way to gain control over the future threat
(Rolland 2006). A few of the counselees who presented for
the genetic test for FTD described how they had grown up
feeling they would be next. They had refrained from
investing in significant relationships with persons outside
of the nuclear family because they did not want to burden a
potential partner with having to care for them once they
developed FTD.
In summary, the separation-individuation task for per-
sons in FTD-affected families may thus be corrupted by at
least three phenomena. These include: family enmeshment
in response to a common threat, psychological damage due
to growing up with an FTD-affected parent, and preoccu-
pation with the possibility of becoming symptomatic for
FTD in the future.
A Case Example of Impaired Separation-Individuation
Awoman in her twenties, Eva (pseudonym) presents herself
for genetic counseling for FTD in our center. She is very
ambivalent about the test. On the one hand she finds herself
unable to deal with the uncertainty about her own genetic
status. Eva closely monitors her behavior and cognitive
functions, searching for any symptoms of FTD, which
would confirm her greatest fears. She has refrained from
investing in a “real relationship” because she would not
want to burden a potential partner with her possible FTD.
She believes that in order to know which turn her future
will take, she needs to learn whether or not she will develop
FTD. On the other hand, Eva worries that if she pursues
testing, she is upsetting and betraying her healthy parent,
her mother. Her mother has taken care of her FTD-affected
father for many years and she is terrified of losing her
daughter to FTD as well. Because of her fears she is unable
to support Eva’s pursuit of genetic testing. On the contrary,
the mother wants Eva to support her by refraining from
testing. Eva is afraid of damaging her relationship with her
mother because she realizes that if she has FTD, she will
need her mother to take care of her in the future.
Eva lost her father to FTD in early adulthood, implying
that her father had FTD during her adolescence. During this
period she was ashamed of her father’s behavior and found
it difficult to understand and accept that his emotional
bluntness was due to the disease and not a rejection of her
as a person. Because her mother had a hard time caring for
her father and managing the household, she assisted her
mother with many tasks. Eva felt quite lonely because her
friends were mostly going out and dating whereas she was
continuously worrying about and feeling responsible for the
situation at home. She felt so different from her peers that
she was unable to invest in friendships. When her father
was institutionalized she stayed with her mother because
she did not want to abandon her.
When finally her father died of FTD, Eva allowed
herself to fully consider that she too was at-risk of
developing this disease, and her attention shifted from her
parents to herself. Based on her physical resemblance to her
father she started to believe that there was a real chance that
she would be the next person to develop FTD. Now that her
father had died, Eva suddenly had to start building her own
life. But FTD was looming behind every important decision
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she had to make. For five years she has found herself
unable to make decisions and build a life of her own. This
is why Eva has presented for genetic counseling. However,
her mother’s disapproval is greatly upsetting her. Eva
believes that she will only be able to start living if she
hears that she is not carrying the mutation, and that a
negative test result would also greatly relieve her mother.
In HD the strong impact of a devastating dementia on
familial relationships was amply demonstrated (Duisterhof
and Tibben 2000; Duisterhof et al. 2002; Vamos et al.
2007). Members of HD affected families present more
often with insecure attachment styles than the general
population as a result of growing up with an affected
parent (Van der Meer et al. 2006). Insecure attachment is a
risk factor for adult psychopathology (Mickelson et al.
1997) The uptake rate for HD genetic counseling in the
Netherlands is relatively high, and it has been noted that a
self-selected group of resourceful and psychologically
“healthy” individuals presents for genetic counseling
(Decruyenaere et al. 2003; Tibben 2007). Therefore our
impression of HD counselees may be biased, making
comparisons to FTD counselees difficult. Still, among the
small number of FTD counselees we have observed,
familial opposition to testing has been particularly overt
whereas we are no longer gathering similar impressions
from HD counselees.
The first generation of testees for HD did report experi-
encing similar familial opposition to testing (Martindale
1987). However, HD became a paradigm for genetic testing
and a very active patient organization emerged. The amount
of attention in the medical, clinical and research settings and
in the media have paved the way for at-risk family members
to seek genetic counseling. In particular, the HD patient
organization is helpful to HD at-risk family members. The
HD patient organization works closely with families and
medical professionals, providing information and guidance
regarding long term care and genetic counseling needs, based
on data from longitudinal studies. The organization serves an
educative function in that it offers guidance as to how
families might deal with genetic testing. Although we do not
believe that a patient organization such as the one for HD in
the Netherlands will guide family members through the
entire separation-individuation process, we do think it may
provide some support for that process. Even a highly
enmeshed, damaged family that might at first not welcome
genetic testing, might learn from the patient organization that
individual members should be allowed to make their own
choices with respect to genetic testing. In the Netherlands,
such a patient organization is lacking for FTD. Given the
absence of an educative patient organization, assisting
counselees with individuation regarding genetic test wishes
is a key task for the psychosocial counselor in the clinical
genetics department.
Counseling Recommendations
In FTD genetic counseling we recommend that the
counselor address the degree of separation-individuation
of the counselee and her or his wish for genetic testing.
Questions that may be helpful in assessing the degree of
individuation regarding a test wish are: Has the counselee
confided in any family member that she or he wishes to
pursue genetic testing? Are the counselee’s parents
involved? How did siblings react? Has the counselee
experienced support from the nuclear family? Is there
openness or secrecy with regard to FTD in the nuclear
family? How did the counselee reach the decision to come
for genetic counseling? The answers to such questions will
reveal the extent to which the counselee’s wish for genetic
testing has evolved in a sufficiently individuated manner.
These questions will raise both the counselor’s and the
counselee’s awareness of the context in which the wish for
testing was shaped. If a wish for testing seems mostly
reactive to family dynamics then this may be discussed as
such. The counseling subsequently needs to address what
consequences the genetic test may precipitate other than
freeing oneself of the nuclear family, and whether the
counselee is willing to accept these consequences as well.
Inherent to the wish to escape family enmeshment is the
observation that mobilizing social support from the family
may be particularly difficult for these individuals. Occa-
sionally the psychosocial counselor may be the counselee’s
sole source of support, and if that is the case, then more
than the standard three sessions should be offered.
Genetic counseling is not psychotherapy. Hence, we do not
expect that geneticists will guide counselees completely
through the process of adequate separation-individuation.
However, addressing these issues might increase their
awareness of the need for an independent decision with regard
to testing. Subsequently, adverse effects of deciding in favor
of the test and of either test outcome may be minimized. If
needed, referral for additional psychotherapy may be offered.
Our impressions are based on a small number of testing
cases and their families. Given the low uptake rate it is
difficult to gather empirical data on this particular popula-
tion. We have chosen to share our clinical impressions, and
we invite others to provide their experience with genetic
counseling and testing in FTD families. Through this
discussion we aim to contribute to enhanced genetic
counseling, testing and enriched psychological support of
individuals at-risk for FTD and their families.
In summary, in our department of Clinical Genetics in
Rotterdam, a mere 26 individuals at-risk for FTD have
presented for genetic counseling over the last decade. We
have observed that these counselees experienced pro-
nounced familial opposition to genetic testing. We hypoth-
esize that the low amount of requests for FTD genetic
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counseling is due to inadequate separation-individuation of
the members of FTD affected families. In FTD families
three processes may impair separation-individuation; 1)
family cohesion that becomes too strong in the face of a
threatening illness, leading to enmeshment, 2) growing up
with an FTD-affected parent may lead to inadequate
separation-individuation, and 3) preoccupation with the
future disease may cause at-risk individuals to refrain from
separating from the nuclear family. Furthermore, we
hypothesize that separation-individuation problems do not
similarly influence the acceptance of HD genetic counsel-
ing, due to the educative role of the well-organized patient
organization for HD in the Netherlands. Geneticists should
thus pay attention to the degree of separation-individuation
evident in counselees’ testing wishes. Geneticists should
also be aware that they may represent a major source of
support for FTD counselees, and tailor their approaches,
accordingly.
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